Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
Chronic hepatitis B virus (HBV) infection is a global public health problem, which can cause chronic hepatitis, liver cirrhosis, hepatocellular carcinoma (HCC), and other diseases. Antiviral therapy is the most critical measure to slow down the progression of chronic hepatitis B, prevent or delay ci...
Saved in:
Main Authors: | Huihui Lu (Author), Wei Yi (Author), Fangfang Sun (Author), Zhan Zeng (Author), Lu Zhang (Author), Minghui Li (Author), Yao Xie (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
by: Ye Zheng, et al.
Published: (2022) -
HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
by: Wenhui Wang, et al.
Published: (2022) -
A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
by: Suofeng Sun, et al.
Published: (2019) -
Molecular mechanism for the involvement of nuclear receptor FXR in HBV-associated hepatocellular carcinoma
by: Yong-dong Niu, et al.
Published: (2011) -
The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma
by: Ling Yang, et al.
Published: (2013)